Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1. 29034881 2018
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE A genetic diagnosis of autosomal-dominant polycystic kidney disease (ADPKD) is challenging due to allelic heterogeneity, high GC content, and homology of the PKD1 gene with six pseudogenes. 28378423 2018
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenetic disorder that is caused by mutations in the genes PKD1 and PKD2 encoding polycystin-1 and polycystin-2, respectively. 28432464 2018
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 CausalMutation disease CLINVAR A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. 26938784 2017
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease. 28870863 2017
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease BEFREE PKD2-related autosomal dominant polycystic kidney disease (ADPKD) is widely acknowledged to be of milder severity than PKD1-related disease, but population-based studies depicting the exact burden of the disease are lacking. 28356211 2017
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease CTD_human Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca(2+) in knock-out mouse models of polycystic kidney disease. 28887310 2017
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE The rest of the patient samples also showed few variants in ADPKD (Autosomal Dominant Polycystic Kidney Disease) disease causing genes PKD1 and PKD2 i.e. 27401137 2017
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease. 26632257 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease. 25757501 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease CTD_human Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD. 25877301 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Autosomal dominant polycystic kidney disease (ADPKD) is a renal hereditary disorder associated with increased cardiovascular mortality, due to mutations in polycystin-1 and polycystin-2 genes. 25029430 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE This is the first report of PKD1 mutations and a somatic mutation of the MET oncogene in a pRCC in ADPKD. 26718059 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. 25880449 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease BEFREE Increasing evidence suggests a major role for PKD1 in early and severe cases of ADPKD and some patients with a recessive form. 25646624 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE It is 20 years since the identification of PKD1, the major gene mutated in autosomal dominant polycystic kidney disease (ADPKD), followed closely by the cloning of PKD2. 26200945 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease BEFREE Mutations in Polycystic Kidney Disease proteins (PKD1 or PKD2) are causative for autosomal dominant polycystic kidney disease (ADPKD). 25920554 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited cause of renal failure in adults, and is due to loss-of-function mutations in either the PKD1 or PKD2 genes, which encode polycystin-1 and polycystin-2, respectively. 26718155 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Mutational analysis of PKD1 gene in a Chinese family with autosomal dominant polycystic kidney disease. 26722532 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Mutations in polycystin-1 and transient receptor potential polycystin 2 (TRPP2) account for almost all clinically identified cases of autosomal dominant polycystic kidney disease (ADPKD), one of the most common human genetic diseases. 27071085 2016
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease BEFREE Interaction of polycystin-1 (PC1) and Gα12 is important for development of kidney cysts in autosomal dominant polycystic kidney disease (ADPKD). 25492927 2015
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE Mutations in either the PKD1 or PKD2 genes, which encode polycystin 1 and polycystin 2, are the underlying cause of ADPKD. 25186187 2015
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease BEFREE To mimic human ADPKD in mice more precisely, we reduced the percentage of Pkd1-deficient kidney cells to 8%. 25361818 2015
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 GeneticVariation disease BEFREE This novel insight can be exploited in future clinical trials to optimize the efficiency and avoiding side effects of drugs in the treatment of ADPKD patients with PKD1 mutations. 24193408 2015
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
1.000 Biomarker disease BEFREE PKD1 lays immediately adjacent to TSC2 and deletions involving both genes, the PKD1/TSC2 contiguous gene syndrome (CGS), are characterized by severe ADPKD, plus TSC. mTOR inhibitors have proven effective in reducing angiomyolipoma (AML) in TSC and total kidney volume in ADPKD but without a positive effect on renal function. 26077033 2015